Dutch Biologic Monitor: Fatigue Among Biologic Recipients Across a Range of Immune-Mediated Inflammatory Diseases

June 3-6, 2020; Virtual Meeting
Overall, 7% of adults self-reported biologic-associated fatigue. Compared with patients not reporting fatigue, they were younger and more frequently smoked, were more likely to have Crohn disease, and used infliximab, rituximab, or vedolizumab.
Format: Microsoft PowerPoint (.ppt)
File Size: 205 KB
Released: August 13, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AbbVie Inc.
Gilead Sciences, Inc.

Related Content

Nurse Practitioners: 0.5 AANP contact hours Released: August 5, 2022 Expired: August 31, 2023

Experts review new treatment strategies in IBD and how to address health inequities in patients, from Clinical Care Options (CCO)

Anita Afzali, MD, MPH, MHCM, FACG, AGAF
Program Director
David Hudesman, MD, FACG, AGAF Millie D. Long, MD, MPH, FACG, AGAF
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Physician Assistants: maximum of 1.5 hours of AAPA Category 1 CME credits Released: June 24, 2022 Expired: June 23, 2023

Drs. Anita Afzali, Millie Long, David Hudesman on latest IBD treatments, therapeutic challenges, individualized care, health inequity from Clinical Care Options (CCO)

Anita Afzali, MD, MPH, MHCM, FACG, AGAF
Program Director
David Hudesman, MD, FACG, AGAF Millie D. Long, MD, MPH, FACG, AGAF
Released: May 20, 2022

On-demand webcast featuring an expert panel with insight on new data presented at ECCO 2022 for Crohn disease and ulcerative colitis from Clinical Care Options (CCO)

Uma Mahadevan, MD Bruce E. Sands, MD, MS Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 19, 2022 Expired: May 18, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings